Jane Street’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Jane Street’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-205,700	Closed	-$7.9M	–	9714
2023 Q2	$7.9M	Buy	205,700 +174,900	+568%	+$4.49M	﹤0.01%	2175
2023 Q1	$713K	Buy	+30,800	New	+$734K	﹤0.01%	5683

Jane Street's KDNY Position: Q3 2023 in Review

Jane Street sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 116,221 shares — an estimated $4.47M sold.

Jane Street first reported a position in KDNY in Q1 2018 and held it in 9 quarters. The position peaked at $4.47M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Jane Street reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Jane Street sold 116,221 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $4.47M.
Jane Street first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Jane Street's Chinook Therapeutics, Inc. Common Stock position peaked at $4.47M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.